MCCORMICK FRANK bought BBIO

September 5, 2025 · Form 4 insider transaction

MCCORMICK FRANK bought 74,000 shares of BridgeBio Pharma, Inc. at $11.92 per share, a transaction worth $882.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
74,000
Price
$11.92
Total value
$882.1K
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 5, 2025
Filing dateSeptember 8, 2025
Shares owned after157,275
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR